#BEGIN_DRUGCARD DB08803

# AHFS_Codes:
Not Available

# ATC_Codes:
R01AA13

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Thymazen

# CAS_Registry_Number:
24243-97-8

# ChEBI_ID:
Not Available

# Chemical_Formula:
C14H20N2O

# Chemical_IUPAC_Name:
2-[5-methyl-2-(propan-2-yl)phenoxymethyl]-4,5-dihydro-1H-imidazole

# Chemical_Structure:
Not Available

# Creation_Date:
2010-10-15 10:48:02 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Tymazoline is a nasal preparation.

# Dosage_Forms:
Liquid	Nasal

# Drug_Category:
Sympathomimetics
Vasoconstrictor Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
2481638	Levrier J, Molon-Noblot S, Duval D, Lloyd KG: A new ex vivo method for the study of nasal drops on ciliary function. Fundam Clin Pharmacol. 1989;3(5):471-82.
9674465	Lorino AM, Lofaso F, Drogou I, Abi-Nader F, Dahan E, Coste A, Lorino H: Effects of different mechanical treatments on nasal resistance assessed by rhinometry. Chest. 1998 Jul;114(1):166-70.

# Drug_Type:
Approved
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Tymazoline

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H20N2O/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16)

# InChI_Key:
InChIKey=QRORCRWSRPKEHR-UHFFFAOYSA-N

# Indication:
For the treatment of Inflammation of the lining of the nose and paranasal sinuses and allergic inflammation of nasopharyngeal.

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
D07373

# LIMS_Drug_ID:
8810

# Mechanism_Of_Action:
Thymazen causes vasoconstriction of the nasal mucosa, reducing congestion and thus the swelling of the mucosa. Also reduces the secretions from the nose. Thymazen acts on alpha-adrenergic receptors, which reduces local inflammation of the nasal mucosa especially if their cause is an allergy.

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
232.3214

# Molecular_Weight_Mono:
232.157563272

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA165958422

# Pharmacology:
Tymazoline is a drug with antihistaminic and sympathomimetic properties. It locally reduces swelling, inflammation and mucosal secretions of the nasal passages.

# Predicted_LogP_Hydrophobicity:
3.2

# Predicted_LogS:
-3.3

# Predicted_Water_Solubility:
1.18e-01 g/l

# Primary_Accession_No:
DB08803

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)C1=C(OCC2=NCCN2)C=C(C)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Pernazene

# Synthesis_Reference:
Not Available

# Toxicity:
A large overdose or accidental oral intake, especially in children, may cause excessive sedation with drowsiness, reduced body temperature, heart rate relief and fluctuations in blood pressure and collapse.

# Update_Date:
2013-02-08 16:27:17 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Tymazoline

# pKa_Isoelectric_Point:
Not Available

#END_DRUGCARD DB08803
